A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of FCFD4514S in Patients With Geographic Atrophy
Clinical trial NCT00973011 · COMPLETED
Trial details
- NCT number
- NCT00973011
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2010-07-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.